Literature DB >> 2234253

Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.

A Waaler1, M Svaland, P Fauchald, J A Jakobsen, F Kolmannskog, K J Berg.   

Abstract

The dialyzability of iohexol was examined in patients with chronic renal failure on long-term hemodialysis treatment. Eight patients had iohexol (Omnipaque 240 or 350 mg I/ml) injected in doses between 98 and 1,493 mg I/kg body weight (BW) 25 h (mean time) before start of hemodialysis. Dialysance of iohexol was 81 +/- 15 ml/min (mean +/- SD) compared to 120 +/- 16.8 ml/min for creatinine. Elimination half-life for iohexol during hemodialysis was 3.9 +/- 1.1 h while plasma clearance was 64 +/- 17 ml/min. The distribution volume calculated (0.25 +/- 0.05 liters/kg BW) confirms previous observations with distribution in the extracellular fluid only. Before the start of hemodialysis 36 +/- 28% of the dose injected was eliminated, indicating some extrarenal elimination. After 4 h of hemodialysis 72 +/- 11% of the dose was removed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2234253     DOI: 10.1159/000186105

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography.

Authors:  Po-Tsang Lee; Kang-Ju Chou; Hua-Chang Fang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

Review 2.  Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.

Authors:  Guido van den Berk; Sanne Tonino; Carola de Fijter; Watske Smit; Marcus J Schultz
Journal:  Crit Care       Date:  2005-01-07       Impact factor: 9.097

Review 3.  Contrast-associated acute kidney injury: does it really exist, and if so, what to do about it?

Authors:  Wim Vandenberghe; Eric Hoste
Journal:  F1000Res       Date:  2019-05-29

4.  Cholecystitis and Cholangitis during Continuous Renal Replacement Therapy in a Patient with Retroperitoneal Hemorrhage Requiring Large Amounts of Contrast Medium for the Assessment and Intervention.

Authors:  Kohsaku Goto; Yu Shimizu; Toshiya Kojima; Norifumi Takeda; Katsuhito Fujiu; Issei Komuro
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.